Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Blood sugar control and kidney damage factors in type 2 diabetes

Studies factors tied to poor blood sugar in type 2 diabetes.

Key facts

Who runs it
Coordinación de Investigación en Salud, Mexico
Where
Mexico City, MexicoSee the 3 sites
Trial code
Registry title
Type 2 Diabetes and Associated Factors in Mexico
Status
Enrolling by invitation
People taking part
1,000 people, planned
Started
1 Apr 2025
Planned end
30 Dec 2025
Type of study
Observational
Treatments tested
  • Clinical and Molecular Assessment
Record updated
4 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who receive care at Family Medicine Units in Coahuila, Jalisco, or Veracruz, in Mexico.

Age
18 years or older.
Sex
All sexes can join.
Disease stage
An established diagnosis of type 2 diabetes mellitus (T2D). No specific stage is named.
Earlier treatment
Current use of steroids is not allowed. Bariatric surgery in the past is not allowed.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • Current use of steroids
  • Inflammatory or autoimmune illness, such as rheumatoid arthritis, lupus, multiple sclerosis, psoriatic arthritis or gout
  • Tobacco use in the last 3 months
  • Severe obesity with BMI over 40 kg/m2

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adults 18 years of age or older
  • Established diagnosis of Type 2 Diabetes Mellitus (T2D)
  • Patients receiving care at Family Medicine Units in Coahuila, Jalisco, or Veracruz
  • Willingness to voluntarily participate in the study
  • Ability to understand the study procedures and provide written informed consent

Who cannot take part

  • Current use of steroids
  • Concomitant illness with inflammatory or autoimmune component (rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriatic arthritis, gout)
  • History of cerebrovascular disease, heart failure or kidney failure that required hospitalization in the previous month
  • History of infection in the previous 10 days (respiratory tract infection, gastroenteritis, urinary tract infection, soft tissue infection)
  • Severe obesity with BMI > 40 kg/m2. History of bariatric surgery
  • Pregnant or lactating mother
  • Tobacco use (in the last 3 months)

Where in Mexico

  • Coordinación de Investigación en SaludMexico City, MexicoNo longer taking part
  • División de Investigación en SaludMexico City, MexicoNo longer taking part
  • Instituto Mexicano del Seguro SocialMexico City, MexicoNo longer taking part

About the trial

What the trial wants to find out

The goal of this observational cross-sectional multicenter study is to identify clinical, lifestyle, metabolic, inflammatory, and genetic factors associated with glycemic control and complications of Type 2 Diabetes (T2D) in adult patients in Mexico.

Read full original descriptionShow less

The main questions it aims to answer are:

Which molecular and clinical factors are associated with poor glycemic control (HbA1c > 7%)?

Which factors are linked to the presence of diabetic nephropathy (GFR < 60 mL/min/1.73 m²)?

Participants:

Provide informed consent and clinical history.

Undergo a clinical and physical evaluation (including six-minute walk test).

Complete lifestyle, dietary, and therapeutic adherence questionnaires.

Provide blood samples for biochemical, inflammatory, and transcriptomic (RNA-Seq) analysis.

Researchers integrate clinical, biochemical, and transcriptomic data using statistical modeling to identify a characteristic molecular fingerprint of poor metabolic control and diabetes-related complications.

The group in the trial

  • Adults with Type 2 Diabetes

    This cohort included adult patients (≥18 years) with a confirmed diagnosis of Type 2 Diabetes Mellitus. Participants were recruited from Family Medicine Units in Coahuila, Jalisco, and Veracruz, Mexico. All underwent clinical evaluation, lifestyle and dietary assessments, functional testing, and blood sampling for biochemical and transcriptomic analysis

    Treatment: Clinical and Molecular Assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Comprehensive Study of Associated Factors With Type 2 Diabetes in Mexico: Protocol
Plain-language title
Blood sugar control and kidney damage factors in type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 December 2025